首页> 外文会议>PUMC-CCF International Anesthesia Symposium; 20070810-14; Beijing(CN) >Perioperative Anesthetic Management for the Excision of Pheochromocytoma
【24h】

Perioperative Anesthetic Management for the Excision of Pheochromocytoma

机译:嗜铬细胞瘤切除术的围手术期麻醉管理

获取原文
获取原文并翻译 | 示例

摘要

Although surgical treatment for patients with pheochromocytoma and its perioperative management has been well developed in recent years, anesthetic management is still highly stressful during the resection of "complicated" pheochromocytoma, such as catechlamine cardiomyopathy, pheochromocytoma crisis, multiple endocrine neoplasia (MEN), and severe surgical difficulties(e.g. location in the heart, liver, or a giant pheochromocytoma surrounding large vessels), etc. The anesthetic management for the excision of pheochromocytoma not only includes selects appropriate anesthetics for the surgical procedures, but also extends to the preoperative preparation and circulatory support postoperatively. It is essential for anesthesiologist to make individualized protocols for these high-risk surgical procedures, based on a thorough understanding of the pathophysiological characteristics of pheochromocytomas and related surgical procedures, as well as good communication among the specialists involved in the treatment.
机译:尽管近年来对嗜铬细胞瘤患者的手术治疗及其围术期治疗已得到很好的发展,但是在切除“复杂的”嗜铬细胞瘤时,如儿茶酚胺心肌病,嗜铬细胞瘤危机,多发性内分泌肿瘤(MEN)和严重的手术困难(例如,位于心脏,肝脏或大血管周围的巨大嗜铬细胞瘤的位置)等。切除嗜铬细胞瘤的麻醉管理不仅包括为手术程序选择合适的麻醉剂,而且还扩展到术前准备和术后循环系统的支持。对于麻醉医师,必须根据对嗜铬细胞瘤的病理生理特征和相关手术程序的透彻了解,以及与治疗有关的专家之间的良好沟通,为这些高风险的手术程序制定个性化的方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号